Overview

Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.

Status:
Recruiting

Trial end date:
2022-03-01

Target enrollment:
0

Participant gender:
All

Summary

Efficacy of tranexamic acid on blood loss during percutaneous nephrolithotomy. a double-blind, placebo-controlled randomized clinical trial.

Phase:

N/A

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

Kafrelsheikh University

Treatments:

Tranexamic Acid

Criteria

Inclusion Criteria:

- Patient 18 years or older

- Stones ≥ 2 cm and/or mild to moderate hydronephrosis.

Exclusion Criteria:

- Age <18 years or Pregnancy

- Bilateral simultaneous PCNL

- Morbid obesity (BMI >40)

- Refuse to complete study requirements

- Untreated UTI

- Atypical bowel interposition by CT

- Tumour in the presumptive access tract area or Potential malignant kidney tumour